SOLID CANCERS
Clinical trials for SOLID CANCERS explained in plain language.
Never miss a new study
Get alerted when new SOLID CANCERS trials appear
Sign up with your email to follow new studies for SOLID CANCERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug targets hard-to-treat cancers with EGFR marker
Disease control Not yet recruitingThis study tests an experimental drug called JY016 in people with advanced solid tumors that have a protein called EGFR on their cells. The goal is to find a safe dose and see if the drug can shrink tumors. About 228 adults with cancers like lung, pancreatic, or colorectal cancer…
Matched conditions: SOLID CANCERS
Phase: PHASE1, PHASE2 • Sponsor: Biotech Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 08:10 UTC
-
600 cancer patients to help unlock secrets of immunotherapy
Knowledge-focused Not yet recruitingThis study will follow 600 people with early-stage solid cancers (like lung, head and neck, melanoma, or bladder cancer) who receive immunotherapy before surgery. Researchers will collect blood and tumor samples to find biological markers that show whether the treatment is workin…
Matched conditions: SOLID CANCERS
Phase: NA • Sponsor: Institut Claudius Regaud • Aim: Knowledge-focused
Last updated May 26, 2026 08:16 UTC
-
Can a simple test predict who will have dangerous reactions to immunotherapy?
Knowledge-focused Not yet recruitingThis study looks for a way to predict which cancer patients will have severe side effects from immunotherapy drugs. Researchers will collect blood, stool, and imaging data from 160 adults with solid tumors before and during treatment. The goal is to create a 'signature' that can …
Matched conditions: SOLID CANCERS
Phase: NA • Sponsor: Assistance Publique Hopitaux De Marseille • Aim: Knowledge-focused
Last updated May 20, 2026 11:56 UTC